X-112631425-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000371968.8(LHFPL1):c.658C>T(p.Pro220Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,088,632 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000371968.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHFPL1 | NM_178175.4 | c.658C>T | p.Pro220Ser | missense_variant | 4/4 | ENST00000371968.8 | NP_835469.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHFPL1 | ENST00000371968.8 | c.658C>T | p.Pro220Ser | missense_variant | 4/4 | 1 | NM_178175.4 | ENSP00000361036 | P1 | |
LHFPL1 | ENST00000478229.1 | n.478C>T | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000111 AC: 2AN: 179984Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 64640
GnomAD4 exome AF: 0.0000138 AC: 15AN: 1088632Hom.: 0 Cov.: 29 AF XY: 0.00000563 AC XY: 2AN XY: 355422
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.658C>T (p.P220S) alteration is located in exon 4 (coding exon 3) of the LHFPL1 gene. This alteration results from a C to T substitution at nucleotide position 658, causing the proline (P) at amino acid position 220 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at